Roth Capital Downgrades Orion Energy Sys to Neutral, Lowers Price Target to $7
Roth Capital analyst Craig Irwin downgrades Orion Energy Sys (NASDAQ:OESX) from Buy to Neutral and lowers the price target from $14 to $7.
Stifel Downgrades Immunovant to Hold, Lowers Price Target to $9
Stifel analyst Derek Archila downgrades Immunovant (NASDAQ:IMVT) from Buy to Hold and lowers the price target from $28 to $9.
Why This F5 Networks Analyst Is Turning Bearish
F5 Networks, Inc’s (NASDAQ: FFIV) growth targets appear too optimistic, with the market “rapidly transitioning to cloud-based architectures,” where the company has a lower share, according to Goldman Sachs.
WBB Securities Downgrades Redhill Biopharma to Buy, Lowers Price Target to $16
WBB Securities analyst Steve Brozak downgrades Redhill Biopharma (NASDAQ:RDHL) from Strong Buy to Buy and lowers the price target from $17 to $16.
Barclays Downgrades US Silica Holdings to Underweight, Lowers Price Target to $10
Barclays analyst David Anderson downgrades US Silica Holdings (NYSE:SLCA) from Equal-Weight to Underweight and lowers the price target from $12 to $10.
CFRA Downgrades Boeing to Buy, Lowers Price Target to $350
CFRA downgrades Boeing (NYSE:BA) from Hold to Buy and lowers the price target from $427 to $350.
Benzinga’s Top Upgrades, Downgrades For January 22, 2020
Upgrades Citigroup changed the rating for Comerica Inc (NYSE:CMA) from Sell to Neutral. Comerica earned $1.85 in the fourth quarter, compared…
Buckingham Downgrades Hartford Financial Servs to Neutral, Announces $63 Price Target
Buckingham downgrades Hartford Financial Servs (NYSE:HIG) from Buy to Neutral and announces $63 price target.
Wells Fargo Downgrades Allergan to Equal-Weight, Announces $198 Price Target
Wells Fargo analyst David Maris downgrades Allergan (NYSE:AGN) from Overweight to Equal-Weight and announces $198 price target.